News Roundup: September 11 to September 16
Your weekly roundup of the latest news from Drug Topics®.
Mitigating Costs of Cancer Treatment: The Role of Pharmacists
Cancer care is expensive, but pharmacists can help.
Using Digital Tools to Improve Reporting of At-Home COVID-19 Testing
At-home COVID-19 testing is convenient, but impacts the number of reported cases. Could a digital tool help improve reporting to public health agencies?
Women and CBD: Increased Interest, but Caution Is Warranted
CBD can be used to treat a myriad of women’s health conditions, but research is still limited.
First Immunotherapy Combo Treatment Approved for Biliary Tract Cancers
FDA approves durvalumab to treat biliary tract cancer in combination with chemotherapy.
The Evolution of the CBD Regulatory Landscape
No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
